Barclays’s FT Vest US Equity Enhance & Moderate Buffer ETF March XMAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$196K Sell
4,589
-408
-8% -$17.2K ﹤0.01% 3728
2026
Q1
$202K Sell
4,997
-10
-0.2% -$402 ﹤0.01% 3677
2025
Q4
$200K Sell
5,007
-602
-11% -$23.8K ﹤0.01% 4315
2025
Q3
$220K Sell
5,609
-156
-3% -$6.05K ﹤0.01% 4249
2025
Q2
$221K Buy
5,765
+1,775
+44% +$65.7K ﹤0.01% 4213
2025
Q1
$147K Sell
3,990
-1,536
-28% -$56.2K ﹤0.01% 4216
2024
Q4
$200K Buy
5,526
+1,160
+27% +$41.6K ﹤0.01% 4310
2024
Q3
$155K Buy
+4,366
New +$152K ﹤0.01% 4421

Other funds holding XMAR

Barclays's XMAR Position: Q2 2026 in Review

Barclays reduced its FT Vest US Equity Enhance & Moderate Buffer ETF March (XMAR) stake by 8.2% in Q2 2026, selling an estimated $17.2K and leaving 4,589 shares worth $196K. The position accounts for ﹤0.01% of the portfolio, ranked #3728.

Barclays first reported a position in XMAR in Q3 2024 and has held it in 8 quarters since. The position peaked at $221K in Q2 2025. 73 funds tracked by Wall St. Rank hold XMAR as of Q2 2026.

  • Barclays held 4,589 shares of FT Vest US Equity Enhance & Moderate Buffer ETF March worth $196K as of Q2 2026.
  • Barclays sold 408 FT Vest US Equity Enhance & Moderate Buffer ETF March shares in Q2 2026, an estimated $17.2K.
  • FT Vest US Equity Enhance & Moderate Buffer ETF March made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3728 holding.
  • Barclays first reported a position in FT Vest US Equity Enhance & Moderate Buffer ETF March in Q3 2024 and has held it in 8 quarters since.
  • Barclays's FT Vest US Equity Enhance & Moderate Buffer ETF March position peaked at $221K in Q2 2025.
  • 73 funds tracked by Wall St. Rank held FT Vest US Equity Enhance & Moderate Buffer ETF March as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.